The major players in the high-content screening market areGE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (U.S.), and Becton, Dickinson and Company (U.S.).Some of the other leading players in this market include Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.),Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).
“Reportsnreports.com include new market research report" Non-Invasive Prenatal Testing (NIPT) Market - Attractiveness, Competitive Landscape and Forecasts" to its huge collection of research reports.
Get Sample Copy for Professional Insights @ www.reportsnreports.com/contacts/r…aspx?name=944663
By product, the non-invasive prenatal testing market is segmented into consumables and instruments. In 2016, the consumables segment accounted for the largest share of the market.
The high demand due to the recurring requirement of consumables as compared to instruments is a key driver for the growth of this product segment.
On the basis of method, the market is segmented into ultrasound detection, biochemical screening tests, fetal cells in maternal blood tests, and cell-free DNA in maternal plasma tests.The ultrasound detection segment dominated the market in 2016.
However, the cell-free DNA in maternal plasma tests segment is expected to grow at the highest CAGR. This is mainly attributed to the increasing demand for cf-DNA based techniques in NIPT testing and rising government initiatives to provide prenatal services.
On the basis of application, the market is segmented into Trisomy, micro deletion syndrome, and other applications. Trisomy commands the largest and fastest-growing application segment of the global market in 2016.
This is attributed to factors such as increasing maternal age and rising incidence of chromosomal abnormalities.
On the basis of end user, the market is classified into diagnostic laboratories and hospitals. In 2016, the diagnostic laboratories segment accounted for the largest share of the market.
Growth in this end-user segment can be attributed to the rising incidence of chromosomal abnormalities and increasing initiatives by companies to provide advanced equipment to diagnostic laboratories.
Browse complete Non-Invasive Prenatal Testing Market by type 2017-2022 by new Service spreads across 150 pages profiling 10 companies and supported with 110 tables and 48 figures available at www.reportsnreports.com/reports/94…-st-to-2021.html
Non-Invasive Prenatal Testing Market, By Product
Assay Kits & Reagents
Next-Generation Sequencing Systems
Polymerase Chain Reaction Instruments
Non-Invasive Prenatal Testing Market, By Application
Non-Invasive Prenatal Testing Market, By End User
Access ALL Data on this Professional Insight @ www.reportsnreports.com/contacts/d…aspx?name=944663
Fundamental from Table of Content
12 Company Profile
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.2 Ge Healthcare (A Wholly Owned Subsidiary of General Electric Company)
12.3 Koninklijke Philips N.V.
12.4 Illumina, Inc.
12.5 Thermo Fisher Scientific, Inc.
12.6 F. Hoffman-La Roche Ltd.
12.7 Pacific Biosciences of California, Inc.
12.8 Perkinelmer, Inc.
12.9 Qiagen N.V.
12.10 Agilent Technologies, Inc.
12.11 Beijing Genomics Institute
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.